CA2758823A1

CA2758823A1 - Protein phosphatase 2a-activating agents

Protein phosphatase 2a-activating agents Download PDF

Info

Publication number: CA2758823A1
Authority: CA; Canada
Prior art keywords: chroman; enyl; yloxy; dimethyl; group
Prior art date: 2009-04-13
Legal status : Abandoned

Application number

CA2758823A

Other languages

English (en)

French (fr)

Inventor

Ching-Shih Chen

Dasheng Wang

Samuel K. Kulp

Current Assignee

Ohio State University Research Foundation

Original Assignee

Ohio State University Research Foundation

Priority date

2009-04-13

Filing date

2010-04-13

Publication date

2010-10-21

2010-04-13 Application filed by Ohio State University Research Foundation filed Critical Ohio State University Research Foundation

2010-10-21 Publication of CA2758823A1 publication Critical patent/CA2758823A1/en

Status Abandoned legal-status Critical Current

Links

102000045595 Phosphoprotein Phosphatases Human genes 0.000 title 1
108700019535 Phosphoprotein Phosphatases Proteins 0.000 title 1
150000001875 compounds Chemical class 0.000 claims abstract description 86
206010028980 Neoplasm Diseases 0.000 claims abstract description 56
108010080146 androgen receptors Proteins 0.000 claims abstract description 51
102000001307 androgen receptors Human genes 0.000 claims abstract description 51
230000000694 effects Effects 0.000 claims abstract description 48
206010060862 Prostate cancer Diseases 0.000 claims abstract description 24
208000000236 Prostatic Neoplasms Diseases 0.000 claims abstract description 24
230000001419 dependent effect Effects 0.000 claims abstract description 11
102000006478 Protein Phosphatase 2 Human genes 0.000 claims abstract description 6
108010058956 Protein Phosphatase 2 Proteins 0.000 claims abstract description 6
201000011510 cancer Diseases 0.000 claims description 43
-1 4,8-dimethyl-non-1-enyl Chemical group 0.000 claims description 35
238000000034 method Methods 0.000 claims description 35
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 22
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 19
239000000203 mixture Substances 0.000 claims description 19
229910052739 hydrogen Inorganic materials 0.000 claims description 18
239000001257 hydrogen Substances 0.000 claims description 18
150000003839 salts Chemical class 0.000 claims description 17
230000001965 increasing effect Effects 0.000 claims description 10
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
238000011161 development Methods 0.000 claims description 3
IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical class OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 abstract description 68
238000011282 treatment Methods 0.000 abstract description 26
239000008194 pharmaceutical composition Substances 0.000 abstract description 7
210000004027 cell Anatomy 0.000 description 93
101710154778 Thymidylate synthase 1 Proteins 0.000 description 53
230000014509 gene expression Effects 0.000 description 25
239000003795 chemical substances by application Substances 0.000 description 21
229940116254 phosphonic acid Drugs 0.000 description 21
108090000623 proteins and genes Proteins 0.000 description 21
101100096476 Bacillus subtilis (strain 168) splB gene Proteins 0.000 description 20
101100478849 Bifidobacterium adolescentis (strain ATCC 15703 / DSM 20083 / NCTC 11814 / E194a) sucP gene Proteins 0.000 description 20
101100421425 Drosophila melanogaster Sply gene Proteins 0.000 description 20
101150099060 SGPL1 gene Proteins 0.000 description 20
229940079593 drug Drugs 0.000 description 18
239000003814 drug Substances 0.000 description 18
102000004169 proteins and genes Human genes 0.000 description 18
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 16
108010055717 JNK Mitogen-Activated Protein Kinases Proteins 0.000 description 15
102000016914 ras Proteins Human genes 0.000 description 15
210000000064 prostate epithelial cell Anatomy 0.000 description 14
230000011664 signaling Effects 0.000 description 14
125000004435 hydrogen atom Chemical group [H]* 0.000 description 13
125000000217 alkyl group Chemical group 0.000 description 11
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 10
102000019145 JUN kinase activity proteins Human genes 0.000 description 10
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 10
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 10
125000004432 carbon atom Chemical group C* 0.000 description 10
238000009472 formulation Methods 0.000 description 10
230000001404 mediated effect Effects 0.000 description 10
239000013612 plasmid Substances 0.000 description 10
239000002253 acid Substances 0.000 description 9
239000013543 active substance Substances 0.000 description 9
108010007457 Extracellular Signal-Regulated MAP Kinases Proteins 0.000 description 8
102000007665 Extracellular Signal-Regulated MAP Kinases Human genes 0.000 description 8
206010062904 Hormone-refractory prostate cancer Diseases 0.000 description 8
239000006228 supernatant Substances 0.000 description 8
101150029129 AR gene Proteins 0.000 description 7
230000004913 activation Effects 0.000 description 7
239000003098 androgen Substances 0.000 description 7
125000003118 aryl group Chemical group 0.000 description 7
231100000504 carcinogenesis Toxicity 0.000 description 7
125000004122 cyclic group Chemical group 0.000 description 7
239000012139 lysis buffer Substances 0.000 description 7
239000000463 material Substances 0.000 description 7
239000002609 medium Substances 0.000 description 7
238000001262 western blot Methods 0.000 description 7
208000005623 Carcinogenesis Diseases 0.000 description 6
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 6
108010072866 Prostate-Specific Antigen Proteins 0.000 description 6
102000007066 Prostate-Specific Antigen Human genes 0.000 description 6
230000036952 cancer formation Effects 0.000 description 6
230000007423 decrease Effects 0.000 description 6
201000010099 disease Diseases 0.000 description 6
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
231100000673 dose–response relationship Toxicity 0.000 description 6
230000006870 function Effects 0.000 description 6
238000011534 incubation Methods 0.000 description 6
210000002307 prostate Anatomy 0.000 description 6
239000000126 substance Substances 0.000 description 6
125000001424 substituent group Chemical group 0.000 description 6
230000008685 targeting Effects 0.000 description 6
210000001519 tissue Anatomy 0.000 description 6
230000037426 transcriptional repression Effects 0.000 description 6
229920000936 Agarose Polymers 0.000 description 5
108010039627 Aprotinin Proteins 0.000 description 5
VGGGPCQERPFHOB-MCIONIFRSA-N Bestatin Chemical compound CC(C)C[C@H](C(O)=O)NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1 VGGGPCQERPFHOB-MCIONIFRSA-N 0.000 description 5
VGGGPCQERPFHOB-UHFFFAOYSA-N Bestatin Natural products CC(C)CC(C(O)=O)NC(=O)C(O)C(N)CC1=CC=CC=C1 VGGGPCQERPFHOB-UHFFFAOYSA-N 0.000 description 5
108020004414 DNA Proteins 0.000 description 5
GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 5
239000005089 Luciferase Substances 0.000 description 5
108091000080 Phosphotransferase Proteins 0.000 description 5
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
239000006180 TBST buffer Substances 0.000 description 5
108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 5
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 5
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 5
MGSKVZWGBWPBTF-UHFFFAOYSA-N aebsf Chemical compound NCCC1=CC=C(S(F)(=O)=O)C=C1 MGSKVZWGBWPBTF-UHFFFAOYSA-N 0.000 description 5
238000010171 animal model Methods 0.000 description 5
229960004405 aprotinin Drugs 0.000 description 5
230000008901 benefit Effects 0.000 description 5
230000015556 catabolic process Effects 0.000 description 5
239000003153 chemical reaction reagent Substances 0.000 description 5
238000006731 degradation reaction Methods 0.000 description 5
230000030609 dephosphorylation Effects 0.000 description 5
238000006209 dephosphorylation reaction Methods 0.000 description 5
238000001114 immunoprecipitation Methods 0.000 description 5
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 5
GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 5
108010052968 leupeptin Proteins 0.000 description 5
239000007788 liquid Substances 0.000 description 5
230000007246 mechanism Effects 0.000 description 5
108020004999 messenger RNA Proteins 0.000 description 5
AFVFQIVMOAPDHO-UHFFFAOYSA-N methanesulfonic acid Substances CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 5
229940098779 methanesulfonic acid Drugs 0.000 description 5
230000026731 phosphorylation Effects 0.000 description 5
238000006366 phosphorylation reaction Methods 0.000 description 5
102000020233 phosphotransferase Human genes 0.000 description 5
239000000047 product Substances 0.000 description 5
230000019491 signal transduction Effects 0.000 description 5
150000003384 small molecules Chemical class 0.000 description 5
230000001629 suppression Effects 0.000 description 5
238000003786 synthesis reaction Methods 0.000 description 5
230000001225 therapeutic effect Effects 0.000 description 5
238000001890 transfection Methods 0.000 description 5
229950009811 ubenimex Drugs 0.000 description 5
102000007317 Farnesyltranstransferase Human genes 0.000 description 4
108010007508 Farnesyltranstransferase Proteins 0.000 description 4
101710154606 Hemagglutinin Proteins 0.000 description 4
108060001084 Luciferase Proteins 0.000 description 4
241001465754 Metazoa Species 0.000 description 4
101710093908 Outer capsid protein VP4 Proteins 0.000 description 4
101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 4
101710176177 Protein A56 Proteins 0.000 description 4
102000001742 Tumor Suppressor Proteins Human genes 0.000 description 4
108010040002 Tumor Suppressor Proteins Proteins 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
239000004480 active ingredient Substances 0.000 description 4
125000001931 aliphatic group Chemical group 0.000 description 4
125000003342 alkenyl group Chemical group 0.000 description 4
229910000147 aluminium phosphate Inorganic materials 0.000 description 4
238000003556 assay Methods 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
239000002775 capsule Substances 0.000 description 4
239000000969 carrier Substances 0.000 description 4
238000005119 centrifugation Methods 0.000 description 4
238000002487 chromatin immunoprecipitation Methods 0.000 description 4
125000001188 haloalkyl group Chemical group 0.000 description 4
239000000185 hemagglutinin Substances 0.000 description 4
125000001072 heteroaryl group Chemical group 0.000 description 4
125000005842 heteroatom Chemical group 0.000 description 4
230000002779 inactivation Effects 0.000 description 4
239000003112 inhibitor Substances 0.000 description 4
230000003211 malignant effect Effects 0.000 description 4
210000004379 membrane Anatomy 0.000 description 4
239000012528 membrane Substances 0.000 description 4
238000011275 oncology therapy Methods 0.000 description 4
108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 description 4
239000002953 phosphate buffered saline Substances 0.000 description 4
NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
230000036515 potency Effects 0.000 description 4
230000002265 prevention Effects 0.000 description 4
230000009467 reduction Effects 0.000 description 4
125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 4
239000000725 suspension Substances 0.000 description 4
238000013518 transcription Methods 0.000 description 4
230000035897 transcription Effects 0.000 description 4
210000004881 tumor cell Anatomy 0.000 description 4
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 3
102100036279 DNA (cytosine-5)-methyltransferase 1 Human genes 0.000 description 3
101000931098 Homo sapiens DNA (cytosine-5)-methyltransferase 1 Proteins 0.000 description 3
102000043136 MAP kinase family Human genes 0.000 description 3
108091054455 MAP kinase family Proteins 0.000 description 3
206010027476 Metastases Diseases 0.000 description 3
CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 3
206010061309 Neoplasm progression Diseases 0.000 description 3
102000012338 Poly(ADP-ribose) Polymerases Human genes 0.000 description 3
108010061844 Poly(ADP-ribose) Polymerases Proteins 0.000 description 3
229920000776 Poly(Adenosine diphosphate-ribose) polymerase Polymers 0.000 description 3
239000012980 RPMI-1640 medium Substances 0.000 description 3
239000007983 Tris buffer Substances 0.000 description 3
238000002679 ablation Methods 0.000 description 3
230000002159 abnormal effect Effects 0.000 description 3
230000009471 action Effects 0.000 description 3
125000002947 alkylene group Chemical group 0.000 description 3
230000001028 anti-proliverative effect Effects 0.000 description 3
230000006907 apoptotic process Effects 0.000 description 3
125000000732 arylene group Chemical group 0.000 description 3
239000013592 cell lysate Substances 0.000 description 3
229940106189 ceramide Drugs 0.000 description 3
ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 3
229960003964 deoxycholic acid Drugs 0.000 description 3
239000002552 dosage form Substances 0.000 description 3
230000003828 downregulation Effects 0.000 description 3
239000012149 elution buffer Substances 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
235000013861 fat-free Nutrition 0.000 description 3
230000012010 growth Effects 0.000 description 3
125000005843 halogen group Chemical group 0.000 description 3
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
238000003119 immunoblot Methods 0.000 description 3
229940027941 immunoglobulin g Drugs 0.000 description 3
239000012133 immunoprecipitate Substances 0.000 description 3
230000001976 improved effect Effects 0.000 description 3
230000005764 inhibitory process Effects 0.000 description 3
238000011835 investigation Methods 0.000 description 3
230000009401 metastasis Effects 0.000 description 3
235000013336 milk Nutrition 0.000 description 3
239000008267 milk Substances 0.000 description 3
210000004080 milk Anatomy 0.000 description 3
VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 3
125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
238000010606 normalization Methods 0.000 description 3
230000037361 pathway Effects 0.000 description 3
239000008188 pellet Substances 0.000 description 3
230000004063 proteosomal degradation Effects 0.000 description 3
238000000746 purification Methods 0.000 description 3
239000007787 solid Substances 0.000 description 3
239000000243 solution Substances 0.000 description 3
239000007858 starting material Substances 0.000 description 3
239000000758 substrate Substances 0.000 description 3
KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical group OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
229910052717 sulfur Inorganic materials 0.000 description 3
239000003826 tablet Substances 0.000 description 3
230000036962 time dependent Effects 0.000 description 3
230000000699 topical effect Effects 0.000 description 3
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
230000005751 tumor progression Effects 0.000 description 3
231100000588 tumorigenic Toxicity 0.000 description 3
230000000381 tumorigenic effect Effects 0.000 description 3
108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 2
102100026596 Bcl-2-like protein 1 Human genes 0.000 description 2
LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
229920002261 Corn starch Polymers 0.000 description 2
108050002772 E3 ubiquitin-protein ligase Mdm2 Proteins 0.000 description 2
102000012199 E3 ubiquitin-protein ligase Mdm2 Human genes 0.000 description 2
108010010803 Gelatin Proteins 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
241000282412 Homo Species 0.000 description 2
101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 description 2
101000950695 Homo sapiens Mitogen-activated protein kinase 8 Proteins 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
102100037808 Mitogen-activated protein kinase 8 Human genes 0.000 description 2
241000699670 Mus sp. Species 0.000 description 2
ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 2
GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
238000002123 RNA extraction Methods 0.000 description 2
238000010240 RT-PCR analysis Methods 0.000 description 2
241000700584 Simplexvirus Species 0.000 description 2
102000040945 Transcription factor Human genes 0.000 description 2
108091023040 Transcription factor Proteins 0.000 description 2
230000003213 activating effect Effects 0.000 description 2
239000012190 activator Substances 0.000 description 2
125000004450 alkenylene group Chemical group 0.000 description 2
230000000259 anti-tumor effect Effects 0.000 description 2
238000003149 assay kit Methods 0.000 description 2
239000011324 bead Substances 0.000 description 2
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
230000010261 cell growth Effects 0.000 description 2
230000004663 cell proliferation Effects 0.000 description 2
230000003833 cell viability Effects 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical group C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 description 2
230000001276 controlling effect Effects 0.000 description 2
239000008120 corn starch Substances 0.000 description 2
239000006071 cream Substances 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical group C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
230000008472 epithelial growth Effects 0.000 description 2
108700002672 epoxomicin Proteins 0.000 description 2
DOGIDQKFVLKMLQ-JTHVHQAWSA-N epoxomicin Chemical compound CC[C@H](C)[C@H](N(C)C(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1 DOGIDQKFVLKMLQ-JTHVHQAWSA-N 0.000 description 2
150000002148 esters Chemical class 0.000 description 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
239000003925 fat Substances 0.000 description 2
235000019197 fats Nutrition 0.000 description 2
239000000796 flavoring agent Substances 0.000 description 2
235000013355 food flavoring agent Nutrition 0.000 description 2
235000003599 food sweetener Nutrition 0.000 description 2
239000012634 fragment Substances 0.000 description 2
108020001507 fusion proteins Proteins 0.000 description 2
102000037865 fusion proteins Human genes 0.000 description 2
239000008273 gelatin Substances 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
235000011852 gelatine desserts Nutrition 0.000 description 2
239000001963 growth medium Substances 0.000 description 2
125000005549 heteroarylene group Chemical group 0.000 description 2
150000002430 hydrocarbons Chemical group 0.000 description 2
125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
125000002768 hydroxyalkyl group Chemical group 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
230000000670 limiting effect Effects 0.000 description 2
231100000053 low toxicity Toxicity 0.000 description 2
238000003468 luciferase reporter gene assay Methods 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
239000007922 nasal spray Substances 0.000 description 2
229940097496 nasal spray Drugs 0.000 description 2
229910052757 nitrogen Inorganic materials 0.000 description 2
231100000252 nontoxic Toxicity 0.000 description 2
230000003000 nontoxic effect Effects 0.000 description 2
125000000962 organic group Chemical group 0.000 description 2
LXCFILQKKLGQFO-UHFFFAOYSA-N p-hydroxybenzoic acid methyl ester Natural products COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
239000000546 pharmaceutical excipient Substances 0.000 description 2
238000003616 phosphatase activity assay Methods 0.000 description 2
125000001189 phytyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])C([H])([H])[C@@](C([H])([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])[C@@](C([H])([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H] 0.000 description 2
239000006187 pill Substances 0.000 description 2
230000004983 pleiotropic effect Effects 0.000 description 2
GUUBJKMBDULZTE-UHFFFAOYSA-M potassium;2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid;hydroxide Chemical compound [OH-].[K+].OCCN1CCN(CCS(O)(=O)=O)CC1 GUUBJKMBDULZTE-UHFFFAOYSA-M 0.000 description 2
230000003389 potentiating effect Effects 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
230000008569 process Effects 0.000 description 2
230000000069 prophylactic effect Effects 0.000 description 2
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
230000017854 proteolysis Effects 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
230000004044 response Effects 0.000 description 2
238000010839 reverse transcription Methods 0.000 description 2
230000002441 reversible effect Effects 0.000 description 2
239000000523 sample Substances 0.000 description 2
229930195734 saturated hydrocarbon Natural products 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
230000004083 survival effect Effects 0.000 description 2
239000003765 sweetening agent Substances 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
239000006188 syrup Substances 0.000 description 2
235000020357 syrup Nutrition 0.000 description 2
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
238000003146 transient transfection Methods 0.000 description 2
230000034512 ubiquitination Effects 0.000 description 2
238000010798 ubiquitination Methods 0.000 description 2
239000003981 vehicle Substances 0.000 description 2
BFWPOGLXJJQOQK-UHFFFAOYSA-N (2,5,7,8-tetramethyl-2-nonyl-3,4-dihydrochromen-6-yl)oxymethanesulfonic acid Chemical compound OS(=O)(=O)COC1=C(C)C(C)=C2OC(CCCCCCCCC)(C)CCC2=C1C BFWPOGLXJJQOQK-UHFFFAOYSA-N 0.000 description 1
HGBPXJMMJMOERZ-UHFFFAOYSA-N (2,5,7,8-tetramethyl-2-nonyl-3,4-dihydrochromen-6-yl)oxymethylphosphonic acid Chemical compound OP(=O)(O)COC1=C(C)C(C)=C2OC(CCCCCCCCC)(C)CCC2=C1C HGBPXJMMJMOERZ-UHFFFAOYSA-N 0.000 description 1
DANIVBBBJORASH-UHFFFAOYSA-N (2-methyl-2-nonyl-3,4-dihydrochromen-6-yl)oxymethanesulfonic acid Chemical compound OS(=O)(=O)COC1=CC=C2OC(CCCCCCCCC)(C)CCC2=C1 DANIVBBBJORASH-UHFFFAOYSA-N 0.000 description 1
XVSWQLIKLIQTAU-UHFFFAOYSA-N (2-methyl-2-nonyl-3,4-dihydrochromen-6-yl)oxymethylphosphonic acid Chemical compound OP(=O)(O)COC1=CC=C2OC(CCCCCCCCC)(C)CCC2=C1 XVSWQLIKLIQTAU-UHFFFAOYSA-N 0.000 description 1
HBZBAMXERPYTFS-SECBINFHSA-N (4S)-2-(6,7-dihydro-5H-pyrrolo[3,2-f][1,3]benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylic acid Chemical compound OC(=O)[C@H]1CSC(=N1)c1nc2cc3CCNc3cc2s1 HBZBAMXERPYTFS-SECBINFHSA-N 0.000 description 1
JWDWLLONDACDQR-UHFFFAOYSA-N 1-[(2-methyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]butane-1-sulfonic acid Chemical compound CCCC(S(O)(=O)=O)OC1=CC=C2OC(CCCCCCCCC)(C)CCC2=C1 JWDWLLONDACDQR-UHFFFAOYSA-N 0.000 description 1
HPDLVZTZDIIKNB-UHFFFAOYSA-N 1-[(2-methyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]ethanesulfonic acid Chemical compound OS(=O)(=O)C(C)OC1=CC=C2OC(CCCCCCCCC)(C)CCC2=C1 HPDLVZTZDIIKNB-UHFFFAOYSA-N 0.000 description 1
PFFPWYGXMBPYJV-UHFFFAOYSA-N 1-[(2-methyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]hexane-1-sulfonic acid Chemical compound CCCCCC(S(O)(=O)=O)OC1=CC=C2OC(CCCCCCCCC)(C)CCC2=C1 PFFPWYGXMBPYJV-UHFFFAOYSA-N 0.000 description 1
INXFQDJHPDRJIP-UHFFFAOYSA-N 1-[(2-methyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]pentane-1-sulfonic acid Chemical compound CCCCC(S(O)(=O)=O)OC1=CC=C2OC(CCCCCCCCC)(C)CCC2=C1 INXFQDJHPDRJIP-UHFFFAOYSA-N 0.000 description 1
NORQBERVSDJNHY-UHFFFAOYSA-N 1-[(2-methyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]propane-1-sulfonic acid Chemical compound CCC(S(O)(=O)=O)OC1=CC=C2OC(CCCCCCCCC)(C)CCC2=C1 NORQBERVSDJNHY-UHFFFAOYSA-N 0.000 description 1
YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Chemical group C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
GCVOVJSTUDFIGB-UHFFFAOYSA-N 2-[(2,5,7,8-tetramethyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]acetic acid Chemical compound OC(=O)COC1=C(C)C(C)=C2OC(CCCCCCCCC)(C)CCC2=C1C GCVOVJSTUDFIGB-UHFFFAOYSA-N 0.000 description 1
RQLBXSUFABQHAD-UHFFFAOYSA-N 2-[(2,5,7,8-tetramethyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]butylphosphonic acid Chemical compound OP(=O)(O)CC(CC)OC1=C(C)C(C)=C2OC(CCCCCCCCC)(C)CCC2=C1C RQLBXSUFABQHAD-UHFFFAOYSA-N 0.000 description 1
ORVXDXOJPQNUDU-UHFFFAOYSA-N 2-[(2,5,7,8-tetramethyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]ethanesulfonic acid Chemical compound OS(=O)(=O)CCOC1=C(C)C(C)=C2OC(CCCCCCCCC)(C)CCC2=C1C ORVXDXOJPQNUDU-UHFFFAOYSA-N 0.000 description 1
SFLVBAUVOAZMHL-UHFFFAOYSA-N 2-[(2,5,7,8-tetramethyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]ethylphosphonic acid Chemical compound OP(=O)(O)CCOC1=C(C)C(C)=C2OC(CCCCCCCCC)(C)CCC2=C1C SFLVBAUVOAZMHL-UHFFFAOYSA-N 0.000 description 1
MXTYBRWNEQDLLT-UHFFFAOYSA-N 2-[(2,5,7,8-tetramethyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]hexylphosphonic acid Chemical compound CCCCC(CP(O)(O)=O)OC1=C(C)C(C)=C2OC(CCCCCCCCC)(C)CCC2=C1C MXTYBRWNEQDLLT-UHFFFAOYSA-N 0.000 description 1
IUESSBLZOIJRRB-UHFFFAOYSA-N 2-[(2,5,7,8-tetramethyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]pentylphosphonic acid Chemical compound CCCC(CP(O)(O)=O)OC1=C(C)C(C)=C2OC(CCCCCCCCC)(C)CCC2=C1C IUESSBLZOIJRRB-UHFFFAOYSA-N 0.000 description 1
MJQLANGNBHGHOC-UHFFFAOYSA-N 2-[(2,5,7,8-tetramethyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]propylphosphonic acid Chemical compound OP(=O)(O)CC(C)OC1=C(C)C(C)=C2OC(CCCCCCCCC)(C)CCC2=C1C MJQLANGNBHGHOC-UHFFFAOYSA-N 0.000 description 1
HNFXGODFFSGDNS-UHFFFAOYSA-N 2-[(2-methyl-2-non-1-enyl-3,4-dihydrochromen-6-yl)oxy]pentylphosphonic acid Chemical compound CCCC(CP(O)(O)=O)OC1=CC=C2OC(C=CCCCCCCC)(C)CCC2=C1 HNFXGODFFSGDNS-UHFFFAOYSA-N 0.000 description 1
REPPGOOCTABMNJ-UHFFFAOYSA-N 2-[(2-methyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]ethylphosphonic acid Chemical compound OP(=O)(O)CCOC1=CC=C2OC(CCCCCCCCC)(C)CCC2=C1 REPPGOOCTABMNJ-UHFFFAOYSA-N 0.000 description 1
CFWHAUBMDPJVIC-UHFFFAOYSA-N 2-[(2-methyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]hexylphosphonic acid Chemical compound CCCCC(CP(O)(O)=O)OC1=CC=C2OC(CCCCCCCCC)(C)CCC2=C1 CFWHAUBMDPJVIC-UHFFFAOYSA-N 0.000 description 1
RDNRUNGOBIBUMF-UHFFFAOYSA-N 2-[(2-methyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]pentylphosphonic acid Chemical compound CCCC(CP(O)(O)=O)OC1=CC=C2OC(CCCCCCCCC)(C)CCC2=C1 RDNRUNGOBIBUMF-UHFFFAOYSA-N 0.000 description 1
UQEMXAJYDLZNRL-UHFFFAOYSA-N 2-[(2-methyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]propylphosphonic acid Chemical compound OP(=O)(O)CC(C)OC1=CC=C2OC(CCCCCCCCC)(C)CCC2=C1 UQEMXAJYDLZNRL-UHFFFAOYSA-N 0.000 description 1
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
DYDZOWNLENXJNJ-UHFFFAOYSA-N 2-[[2-(4,8-dimethylnon-1-enyl)-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-yl]oxy]butane-1-sulfonic acid Chemical compound O1C(C)(C=CCC(C)CCCC(C)C)CCC2=C(C)C(OC(CS(O)(=O)=O)CC)=C(C)C(C)=C21 DYDZOWNLENXJNJ-UHFFFAOYSA-N 0.000 description 1
XATZZEUFRZILQD-UHFFFAOYSA-N 2-[[2-(4,8-dimethylnon-1-enyl)-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-yl]oxy]ethylphosphonic acid Chemical compound OP(=O)(O)CCOC1=C(C)C(C)=C2OC(C=CCC(C)CCCC(C)C)(C)CCC2=C1C XATZZEUFRZILQD-UHFFFAOYSA-N 0.000 description 1
BLQQGBFYXXLNBL-UHFFFAOYSA-N 2-[[2-(4,8-dimethylnonyl)-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-yl]oxy]acetic acid Chemical compound OC(=O)COC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)C)(C)CCC2=C1C BLQQGBFYXXLNBL-UHFFFAOYSA-N 0.000 description 1
IBAWSYRFOYPGNO-UHFFFAOYSA-N 2-[[2-(4,8-dimethylnonyl)-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-yl]oxy]butane-1-sulfonic acid Chemical compound O1C(C)(CCCC(C)CCCC(C)C)CCC2=C(C)C(OC(CS(O)(=O)=O)CC)=C(C)C(C)=C21 IBAWSYRFOYPGNO-UHFFFAOYSA-N 0.000 description 1
ZECKYPRJYVGHRD-UHFFFAOYSA-N 2-[[2-(4,8-dimethylnonyl)-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-yl]oxy]butanoic acid Chemical compound O1C(C)(CCCC(C)CCCC(C)C)CCC2=C(C)C(OC(CC)C(O)=O)=C(C)C(C)=C21 ZECKYPRJYVGHRD-UHFFFAOYSA-N 0.000 description 1
VZNCZFMRXFERRT-UHFFFAOYSA-N 2-[[2-(4,8-dimethylnonyl)-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-yl]oxy]butylphosphonic acid Chemical compound O1C(C)(CCCC(C)CCCC(C)C)CCC2=C(C)C(OC(CP(O)(O)=O)CC)=C(C)C(C)=C21 VZNCZFMRXFERRT-UHFFFAOYSA-N 0.000 description 1
OQIGYUSGWYGSFW-UHFFFAOYSA-N 2-[[2-(4,8-dimethylnonyl)-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-yl]oxy]ethylphosphonic acid Chemical compound OP(=O)(O)CCOC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)C)(C)CCC2=C1C OQIGYUSGWYGSFW-UHFFFAOYSA-N 0.000 description 1
PYGZDYOLJODHRU-UHFFFAOYSA-N 2-[[2-(4,8-dimethylnonyl)-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-yl]oxy]heptanoic acid Chemical compound O1C(C)(CCCC(C)CCCC(C)C)CCC2=C(C)C(OC(CCCCC)C(O)=O)=C(C)C(C)=C21 PYGZDYOLJODHRU-UHFFFAOYSA-N 0.000 description 1
CSWIJBJIABKUEB-UHFFFAOYSA-N 2-[[2-(4,8-dimethylnonyl)-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-yl]oxy]hexane-1-sulfonic acid Chemical compound O1C(C)(CCCC(C)CCCC(C)C)CCC2=C(C)C(OC(CS(O)(=O)=O)CCCC)=C(C)C(C)=C21 CSWIJBJIABKUEB-UHFFFAOYSA-N 0.000 description 1
JAJGEDHKAHDSDB-UHFFFAOYSA-N 2-[[2-(4,8-dimethylnonyl)-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-yl]oxy]hexanoic acid Chemical compound O1C(C)(CCCC(C)CCCC(C)C)CCC2=C(C)C(OC(CCCC)C(O)=O)=C(C)C(C)=C21 JAJGEDHKAHDSDB-UHFFFAOYSA-N 0.000 description 1
YZMVRDGULLBEAF-UHFFFAOYSA-N 2-[[2-(4,8-dimethylnonyl)-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-yl]oxy]hexylphosphonic acid Chemical compound O1C(C)(CCCC(C)CCCC(C)C)CCC2=C(C)C(OC(CP(O)(O)=O)CCCC)=C(C)C(C)=C21 YZMVRDGULLBEAF-UHFFFAOYSA-N 0.000 description 1
YJFJEJQNAHWONM-UHFFFAOYSA-N 2-[[2-(4,8-dimethylnonyl)-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-yl]oxy]pentane-1-sulfonic acid Chemical compound O1C(C)(CCCC(C)CCCC(C)C)CCC2=C(C)C(OC(CS(O)(=O)=O)CCC)=C(C)C(C)=C21 YJFJEJQNAHWONM-UHFFFAOYSA-N 0.000 description 1
AJCHDKOVZRPIPL-UHFFFAOYSA-N 2-[[2-(4,8-dimethylnonyl)-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-yl]oxy]pentanoic acid Chemical compound O1C(C)(CCCC(C)CCCC(C)C)CCC2=C(C)C(OC(CCC)C(O)=O)=C(C)C(C)=C21 AJCHDKOVZRPIPL-UHFFFAOYSA-N 0.000 description 1
RDNWSMIXOVWYRU-UHFFFAOYSA-N 2-[[2-(4,8-dimethylnonyl)-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-yl]oxy]pentylphosphonic acid Chemical compound O1C(C)(CCCC(C)CCCC(C)C)CCC2=C(C)C(OC(CP(O)(O)=O)CCC)=C(C)C(C)=C21 RDNWSMIXOVWYRU-UHFFFAOYSA-N 0.000 description 1
DAQARBHYNWIVOC-UHFFFAOYSA-N 2-[[2-(4,8-dimethylnonyl)-2-methyl-3,4-dihydrochromen-6-yl]oxy]ethanesulfonic acid Chemical compound OS(=O)(=O)CCOC1=CC=C2OC(CCCC(C)CCCC(C)C)(C)CCC2=C1 DAQARBHYNWIVOC-UHFFFAOYSA-N 0.000 description 1
GFHNEARGFSTIQQ-UHFFFAOYSA-N 2-[[2-(4,8-dimethylnonyl)-2-methyl-3,4-dihydrochromen-6-yl]oxy]ethylphosphonic acid Chemical compound OP(=O)(O)CCOC1=CC=C2OC(CCCC(C)CCCC(C)C)(C)CCC2=C1 GFHNEARGFSTIQQ-UHFFFAOYSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
WMYTWSATLNWDMG-UHFFFAOYSA-N 3-[(2,5,7,8-tetramethyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]propane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCOC1=C(C)C(C)=C2OC(CCCCCCCCC)(C)CCC2=C1C WMYTWSATLNWDMG-UHFFFAOYSA-N 0.000 description 1
QZZVXSKTRYAKLJ-UHFFFAOYSA-N 3-[(2,5,7,8-tetramethyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]propanoic acid Chemical compound OC(=O)CCOC1=C(C)C(C)=C2OC(CCCCCCCCC)(C)CCC2=C1C QZZVXSKTRYAKLJ-UHFFFAOYSA-N 0.000 description 1
BFLSCLGFZZKDGU-UHFFFAOYSA-N 3-[[2-(4,8-dimethylnonyl)-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-yl]oxy]propanoic acid Chemical compound OC(=O)CCOC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)C)(C)CCC2=C1C BFLSCLGFZZKDGU-UHFFFAOYSA-N 0.000 description 1
IIFBMFHMUHAMKN-UHFFFAOYSA-N 3-[[2-(4,8-dimethylnonyl)-2-methyl-3,4-dihydrochromen-6-yl]oxy]propane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCOC1=CC=C2OC(CCCC(C)CCCC(C)C)(C)CCC2=C1 IIFBMFHMUHAMKN-UHFFFAOYSA-N 0.000 description 1
CCXRLUMFZDUEOS-UHFFFAOYSA-N 3-[[2-(4,8-dimethylnonyl)-2-methyl-3,4-dihydrochromen-6-yl]oxy]propylphosphonic acid Chemical compound OP(=O)(O)CCCOC1=CC=C2OC(CCCC(C)CCCC(C)C)(C)CCC2=C1 CCXRLUMFZDUEOS-UHFFFAOYSA-N 0.000 description 1
AMXPTINCMDTMKE-UHFFFAOYSA-N 4-[(2,5,7,8-tetramethyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]butane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCCOC1=C(C)C(C)=C2OC(CCCCCCCCC)(C)CCC2=C1C AMXPTINCMDTMKE-UHFFFAOYSA-N 0.000 description 1
OZEUUGNATVGTEM-UHFFFAOYSA-N 4-[(2,5,7,8-tetramethyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]butanoic acid Chemical compound OC(=O)CCCOC1=C(C)C(C)=C2OC(CCCCCCCCC)(C)CCC2=C1C OZEUUGNATVGTEM-UHFFFAOYSA-N 0.000 description 1
OPTBXOXBCJWLGI-UHFFFAOYSA-N 4-[[2-(4,8-dimethylnonyl)-2-methyl-3,4-dihydrochromen-6-yl]oxy]butane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCCOC1=CC=C2OC(CCCC(C)CCCC(C)C)(C)CCC2=C1 OPTBXOXBCJWLGI-UHFFFAOYSA-N 0.000 description 1
DHEJJDYXEFFCGA-UHFFFAOYSA-N 4-[[2-(4,8-dimethylnonyl)-2-methyl-3,4-dihydrochromen-6-yl]oxy]butylphosphonic acid Chemical compound OP(=O)(O)CCCCOC1=CC=C2OC(CCCC(C)CCCC(C)C)(C)CCC2=C1 DHEJJDYXEFFCGA-UHFFFAOYSA-N 0.000 description 1
108020003589 5' Untranslated Regions Proteins 0.000 description 1
MNMVGZPMPYCLRH-UHFFFAOYSA-N 5-[(2,5,7,8-tetramethyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]pentane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCCCOC1=C(C)C(C)=C2OC(CCCCCCCCC)(C)CCC2=C1C MNMVGZPMPYCLRH-UHFFFAOYSA-N 0.000 description 1
NLAILVOWPBLRHK-UHFFFAOYSA-N 5-[[2-(4,8-dimethylnonyl)-2-methyl-3,4-dihydrochromen-6-yl]oxy]pentane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCCCOC1=CC=C2OC(CCCC(C)CCCC(C)C)(C)CCC2=C1 NLAILVOWPBLRHK-UHFFFAOYSA-N 0.000 description 1
IUTNDJDDMIJIED-UHFFFAOYSA-N 5-[[2-(4,8-dimethylnonyl)-2-methyl-3,4-dihydrochromen-6-yl]oxy]pentylphosphonic acid Chemical compound OP(=O)(O)CCCCCOC1=CC=C2OC(CCCC(C)CCCC(C)C)(C)CCC2=C1 IUTNDJDDMIJIED-UHFFFAOYSA-N 0.000 description 1
SIGORSQMCFETIU-UHFFFAOYSA-N 6-[(2,5,7,8-tetramethyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]hexane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCCCCOC1=C(C)C(C)=C2OC(CCCCCCCCC)(C)CCC2=C1C SIGORSQMCFETIU-UHFFFAOYSA-N 0.000 description 1
QLTQVALPXDSEFC-UHFFFAOYSA-N 6-[[2-(4,8-dimethylnonyl)-2-methyl-3,4-dihydrochromen-6-yl]oxy]hexane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCCCCOC1=CC=C2OC(CCCC(C)CCCC(C)C)(C)CCC2=C1 QLTQVALPXDSEFC-UHFFFAOYSA-N 0.000 description 1
VYSSEIIMIVBXIE-UHFFFAOYSA-N 6-[[2-(4,8-dimethylnonyl)-2-methyl-3,4-dihydrochromen-6-yl]oxy]hexylphosphonic acid Chemical compound OP(=O)(O)CCCCCCOC1=CC=C2OC(CCCC(C)CCCC(C)C)(C)CCC2=C1 VYSSEIIMIVBXIE-UHFFFAOYSA-N 0.000 description 1
OZNWKZDEOMTBMV-UHFFFAOYSA-N 7-[(2,5,7,8-tetramethyl-2-nonyl-3,4-dihydrochromen-6-yl)oxy]heptanoic acid Chemical compound OC(=O)CCCCCCOC1=C(C)C(C)=C2OC(CCCCCCCCC)(C)CCC2=C1C OZNWKZDEOMTBMV-UHFFFAOYSA-N 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
102100034111 Activin receptor type-1 Human genes 0.000 description 1
101710105225 Activin receptor type-1 Proteins 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
108010011485 Aspartame Proteins 0.000 description 1
241000416162 Astragalus gummifer Species 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
208000026310 Breast neoplasm Diseases 0.000 description 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
241000283707 Capra Species 0.000 description 1
WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
201000009030 Carcinoma Diseases 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 description 1
235000019739 Dicalciumphosphate Nutrition 0.000 description 1
101100030375 Dictyostelium discoideum pho2a gene Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
229930091371 Fructose Natural products 0.000 description 1
239000005715 Fructose Substances 0.000 description 1
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
102000013446 GTP Phosphohydrolases Human genes 0.000 description 1
108091006109 GTPases Proteins 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
108090000965 Insulin-like growth factor binding protein 3 Proteins 0.000 description 1
102100022708 Insulin-like growth factor-binding protein 3 Human genes 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
235000010643 Leucaena leucocephala Nutrition 0.000 description 1
240000007472 Leucaena leucocephala Species 0.000 description 1
206010025323 Lymphomas Diseases 0.000 description 1
231100000002 MTT assay Toxicity 0.000 description 1
238000000134 MTT assay Methods 0.000 description 1
208000034578 Multiple myelomas Diseases 0.000 description 1
101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
101001134300 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Multidomain regulatory protein Rv1364c Proteins 0.000 description 1
101000615835 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Phosphoserine phosphatase SerB2 Proteins 0.000 description 1
101001082202 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Triple specificity protein phosphatase PtpB Proteins 0.000 description 1
101001134301 Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) Multidomain regulatory protein MT1410 Proteins 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
238000010222 PCR analysis Methods 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
102000003992 Peroxidases Human genes 0.000 description 1
108010089430 Phosphoproteins Proteins 0.000 description 1
102000007982 Phosphoproteins Human genes 0.000 description 1
206010035226 Plasma cell myeloma Diseases 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
229920001213 Polysorbate 20 Polymers 0.000 description 1
229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
229940079156 Proteasome inhibitor Drugs 0.000 description 1
108091008611 Protein Kinase B Proteins 0.000 description 1
229940122454 Protein phosphatase 2A inhibitor Drugs 0.000 description 1
239000012083 RIPA buffer Substances 0.000 description 1
239000012979 RPMI medium Substances 0.000 description 1
241000242743 Renilla reniformis Species 0.000 description 1
239000012722 SDS sample buffer Substances 0.000 description 1
229910006069 SO3H Inorganic materials 0.000 description 1
206010039491 Sarcoma Diseases 0.000 description 1
101710082813 Serine/threonine-protein kinase receptor R3 Proteins 0.000 description 1
229920001800 Shellac Polymers 0.000 description 1
208000005718 Stomach Neoplasms Diseases 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
241000282887 Suidae Species 0.000 description 1
108010006785 Taq Polymerase Proteins 0.000 description 1
229940123464 Thiazolidinedione Drugs 0.000 description 1
102000006601 Thymidine Kinase Human genes 0.000 description 1
108020004440 Thymidine kinase Proteins 0.000 description 1
229920001615 Tragacanth Polymers 0.000 description 1
101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
239000007984 Tris EDTA buffer Substances 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
229930003427 Vitamin E Natural products 0.000 description 1
ZAKOWWREFLAJOT-ADUHFSDSSA-N [2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] acetate Chemical group CC(=O)OC1=C(C)C(C)=C2OC(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-ADUHFSDSSA-N 0.000 description 1
XMRXQZDJLXLWAB-UHFFFAOYSA-N [2-(4,8-dimethylnonyl)-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-yl]oxymethylphosphonic acid Chemical compound OP(=O)(O)COC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)C)(C)CCC2=C1C XMRXQZDJLXLWAB-UHFFFAOYSA-N 0.000 description 1
OWKGFJMHUVIVAT-UHFFFAOYSA-N [2-(4,8-dimethylnonyl)-2-methyl-3,4-dihydrochromen-6-yl]oxymethanesulfonic acid Chemical compound OS(=O)(=O)COC1=CC=C2OC(CCCC(C)CCCC(C)C)(C)CCC2=C1 OWKGFJMHUVIVAT-UHFFFAOYSA-N 0.000 description 1
MURDSDTUCMZHJD-UHFFFAOYSA-N [2-(4,8-dimethylnonyl)-2-methyl-3,4-dihydrochromen-6-yl]oxymethylphosphonic acid Chemical compound OP(=O)(O)COC1=CC=C2OC(CCCC(C)CCCC(C)C)(C)CCC2=C1 MURDSDTUCMZHJD-UHFFFAOYSA-N 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
101150063416 add gene Proteins 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
239000000783 alginic acid Substances 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
229960001126 alginic acid Drugs 0.000 description 1
150000004781 alginic acids Chemical class 0.000 description 1
125000003545 alkoxy group Chemical group 0.000 description 1
125000002877 alkyl aryl group Chemical group 0.000 description 1
125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
125000005466 alkylenyl group Chemical group 0.000 description 1
125000000304 alkynyl group Chemical group 0.000 description 1
230000003321 amplification Effects 0.000 description 1
230000003042 antagnostic effect Effects 0.000 description 1
125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
230000001093 anti-cancer Effects 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
125000003710 aryl alkyl group Chemical group 0.000 description 1
IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
239000000605 aspartame Substances 0.000 description 1
229960003438 aspartame Drugs 0.000 description 1
235000010357 aspartame Nutrition 0.000 description 1
239000012131 assay buffer Substances 0.000 description 1
125000004429 atom Chemical group 0.000 description 1
239000003855 balanced salt solution Substances 0.000 description 1
125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000008827 biological function Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
239000000090 biomarker Substances 0.000 description 1
239000004305 biphenyl Chemical group 0.000 description 1
235000010290 biphenyl Nutrition 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
210000000601 blood cell Anatomy 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
210000001185 bone marrow Anatomy 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
229910052794 bromium Inorganic materials 0.000 description 1
UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
238000010805 cDNA synthesis kit Methods 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
125000002837 carbocyclic group Chemical group 0.000 description 1
125000004181 carboxyalkyl group Chemical group 0.000 description 1
150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
150000001735 carboxylic acids Chemical class 0.000 description 1
210000000845 cartilage Anatomy 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
230000001364 causal effect Effects 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000012820 cell cycle checkpoint Effects 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
230000003915 cell function Effects 0.000 description 1
230000006037 cell lysis Effects 0.000 description 1
230000009087 cell motility Effects 0.000 description 1
230000005754 cellular signaling Effects 0.000 description 1
239000013626 chemical specie Substances 0.000 description 1
230000000973 chemotherapeutic effect Effects 0.000 description 1
239000000460 chlorine Substances 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
238000000576 coating method Methods 0.000 description 1
229940110456 cocoa butter Drugs 0.000 description 1
235000019868 cocoa butter Nutrition 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
230000000875 corresponding effect Effects 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
125000000392 cycloalkenyl group Chemical group 0.000 description 1
125000000753 cycloalkyl group Chemical group 0.000 description 1
229940099418 d- alpha-tocopherol succinate Drugs 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000007123 defense Effects 0.000 description 1
239000003405 delayed action preparation Substances 0.000 description 1
230000002939 deleterious effect Effects 0.000 description 1
NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
229940038472 dicalcium phosphate Drugs 0.000 description 1
229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
230000009699 differential effect Effects 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
230000003292 diminished effect Effects 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
FGJLAJMGHXGFDE-UHFFFAOYSA-L disodium;2,3-dihydroxybutanedioate;dihydrate Chemical compound O.O.[Na+].[Na+].[O-]C(=O)C(O)C(O)C([O-])=O FGJLAJMGHXGFDE-UHFFFAOYSA-L 0.000 description 1
230000002222 downregulating effect Effects 0.000 description 1
239000000975 dye Substances 0.000 description 1
239000012636 effector Substances 0.000 description 1
238000001378 electrochemiluminescence detection Methods 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
125000001033 ether group Chemical group 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
238000013213 extrapolation Methods 0.000 description 1
125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
238000000799 fluorescence microscopy Methods 0.000 description 1
229910052731 fluorine Inorganic materials 0.000 description 1
239000011737 fluorine Substances 0.000 description 1
125000001153 fluoro group Chemical group F* 0.000 description 1
235000013305 food Nutrition 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
125000002541 furyl group Chemical group 0.000 description 1
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
206010017758 gastric cancer Diseases 0.000 description 1
239000000499 gel Substances 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
239000008187 granular material Substances 0.000 description 1
239000005090 green fluorescent protein Substances 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
125000000623 heterocyclic group Chemical group 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
125000002883 imidazolyl group Chemical group 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
125000001041 indolyl group Chemical group 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
239000000543 intermediate Substances 0.000 description 1
230000037041 intracellular level Effects 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
230000002601 intratumoral effect Effects 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
239000011630 iodine Substances 0.000 description 1
229910052740 iodine Inorganic materials 0.000 description 1
125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
238000002955 isolation Methods 0.000 description 1
125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
125000001786 isothiazolyl group Chemical group 0.000 description 1
239000007951 isotonicity adjuster Substances 0.000 description 1
125000000842 isoxazolyl group Chemical group 0.000 description 1
239000008101 lactose Substances 0.000 description 1
231100000518 lethal Toxicity 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
239000002502 liposome Substances 0.000 description 1
239000012160 loading buffer Substances 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
238000003670 luciferase enzyme activity assay Methods 0.000 description 1
239000006166 lysate Substances 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
238000007726 management method Methods 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
230000011987 methylation Effects 0.000 description 1
238000007069 methylation reaction Methods 0.000 description 1
125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
229960002216 methylparaben Drugs 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
235000010446 mineral oil Nutrition 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
125000002950 monocyclic group Chemical group 0.000 description 1
229940126619 mouse monoclonal antibody Drugs 0.000 description 1
210000004400 mucous membrane Anatomy 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
125000001624 naphthyl group Chemical group 0.000 description 1
125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 1
230000010309 neoplastic transformation Effects 0.000 description 1
239000002547 new drug Substances 0.000 description 1
125000004971 nitroalkyl group Chemical group 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
238000011580 nude mouse model Methods 0.000 description 1
QNDVLZJODHBUFM-WFXQOWMNSA-N okadaic acid Chemical compound C([C@H](O1)[C@H](C)/C=C/[C@H]2CC[C@@]3(CC[C@H]4O[C@@H](C([C@@H](O)[C@@H]4O3)=C)[C@@H](O)C[C@H](C)[C@@H]3[C@@H](CC[C@@]4(OCCCC4)O3)C)O2)C(C)=C[C@]21O[C@H](C[C@@](C)(O)C(O)=O)CC[C@H]2O QNDVLZJODHBUFM-WFXQOWMNSA-N 0.000 description 1
VEFJHAYOIAAXEU-UHFFFAOYSA-N okadaic acid Natural products CC(CC(O)C1OC2CCC3(CCC(O3)C=CC(C)C4CC(=CC5(OC(CC(C)(O)C(=O)O)CCC5O)O4)C)OC2C(O)C1C)C6OC7(CCCCO7)CCC6C VEFJHAYOIAAXEU-UHFFFAOYSA-N 0.000 description 1
231100000590 oncogenic Toxicity 0.000 description 1
230000002246 oncogenic effect Effects 0.000 description 1
230000005959 oncogenic signaling Effects 0.000 description 1
230000006712 oncogenic signaling pathway Effects 0.000 description 1
210000003463 organelle Anatomy 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
125000001715 oxadiazolyl group Chemical group 0.000 description 1
125000002971 oxazolyl group Chemical group 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
239000003208 petroleum Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
230000009038 pharmacological inhibition Effects 0.000 description 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
125000003367 polycyclic group Chemical group 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
230000001323 posttranslational effect Effects 0.000 description 1
229920001592 potato starch Polymers 0.000 description 1
230000003334 potential effect Effects 0.000 description 1
239000000843 powder Substances 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
239000000651 prodrug Substances 0.000 description 1
229940002612 prodrug Drugs 0.000 description 1
230000002062 proliferating effect Effects 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
229960003415 propylparaben Drugs 0.000 description 1
239000003207 proteasome inhibitor Substances 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
125000003373 pyrazinyl group Chemical group 0.000 description 1
125000003226 pyrazolyl group Chemical group 0.000 description 1
125000002098 pyridazinyl group Chemical group 0.000 description 1
125000004076 pyridyl group Chemical group 0.000 description 1
125000000714 pyrimidinyl group Chemical group 0.000 description 1
125000000168 pyrrolyl group Chemical group 0.000 description 1
125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
230000010076 replication Effects 0.000 description 1
230000001718 repressive effect Effects 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
238000013341 scale-up Methods 0.000 description 1
230000007017 scission Effects 0.000 description 1
238000007790 scraping Methods 0.000 description 1
238000007493 shaping process Methods 0.000 description 1
ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
239000004208 shellac Substances 0.000 description 1
229940113147 shellac Drugs 0.000 description 1
235000013874 shellac Nutrition 0.000 description 1
108091006024 signal transducing proteins Proteins 0.000 description 1
102000034285 signal transducing proteins Human genes 0.000 description 1
229910052710 silicon Inorganic materials 0.000 description 1
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
239000011775 sodium fluoride Substances 0.000 description 1
235000013024 sodium fluoride Nutrition 0.000 description 1
239000011684 sodium molybdate Substances 0.000 description 1
235000015393 sodium molybdate Nutrition 0.000 description 1
TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
229940092162 sodium tartrate dihydrate Drugs 0.000 description 1
239000007892 solid unit dosage form Substances 0.000 description 1
239000012453 solvate Substances 0.000 description 1
238000000527 sonication Methods 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
150000003408 sphingolipids Chemical class 0.000 description 1
238000003153 stable transfection Methods 0.000 description 1
238000010186 staining Methods 0.000 description 1
239000011550 stock solution Substances 0.000 description 1
201000011549 stomach cancer Diseases 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000001384 succinic acid Substances 0.000 description 1
150000003900 succinic acid esters Chemical class 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
150000005846 sugar alcohols Polymers 0.000 description 1
125000004964 sulfoalkyl group Chemical group 0.000 description 1
239000013589 supplement Substances 0.000 description 1
230000003319 supportive effect Effects 0.000 description 1
239000000829 suppository Substances 0.000 description 1
238000012360 testing method Methods 0.000 description 1
125000005247 tetrazinyl group Chemical group N1=NN=NC(=C1)* 0.000 description 1
125000003831 tetrazolyl group Chemical group 0.000 description 1
125000001113 thiadiazolyl group Chemical group 0.000 description 1
150000001467 thiazolidinediones Chemical class 0.000 description 1
125000000335 thiazolyl group Chemical group 0.000 description 1
125000001544 thienyl group Chemical group 0.000 description 1
230000005919 time-dependent effect Effects 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
239000012049 topical pharmaceutical composition Substances 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000009466 transformation Effects 0.000 description 1
238000000844 transformation Methods 0.000 description 1
238000011820 transgenic animal model Methods 0.000 description 1
125000004306 triazinyl group Chemical group 0.000 description 1
125000001425 triazolyl group Chemical group 0.000 description 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
239000003656 tris buffered saline Substances 0.000 description 1
IHIXIJGXTJIKRB-UHFFFAOYSA-N trisodium vanadate Chemical compound [Na+].[Na+].[Na+].[O-][V]([O-])([O-])=O IHIXIJGXTJIKRB-UHFFFAOYSA-N 0.000 description 1
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
239000000225 tumor suppressor protein Substances 0.000 description 1
230000002100 tumorsuppressive effect Effects 0.000 description 1
230000007306 turnover Effects 0.000 description 1
230000003827 upregulation Effects 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
230000035899 viability Effects 0.000 description 1
231100000747 viability assay Toxicity 0.000 description 1
238000003026 viability measurement method Methods 0.000 description 1
210000001835 viscera Anatomy 0.000 description 1
229940046009 vitamin E Drugs 0.000 description 1
235000019165 vitamin E Nutrition 0.000 description 1
239000011709 vitamin E Substances 0.000 description 1
235000012431 wafers Nutrition 0.000 description 1
239000011534 wash buffer Substances 0.000 description 1
239000001993 wax Substances 0.000 description 1
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1